Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clarisse Scherer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neurology. Genetics|January 18, 2024
<i>IRF2BPL</i> Causes Mild Intellectual Disability Followed by Late-Onset AtaxiaSolveig Heide, Claire-Sophie Davoine, Paulina Cunha, et al.
Journal of Huntington'S Disease|February 20, 2025
Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimagingMarie Caillaud, Mickael Laisney, Alexandre Bejanin, et al.
Orphanet Journal of Rare Diseases|February 19, 2018
Cyclosporine A does not prevent second-eye involvement in Leber's hereditary optic neuropathyStéphanie Leruez, Christophe Verny, Dominique Bonneau, et al.
Brain Pathology (Zurich, Switzerland)|December 20, 2022
Design and application of a customizable relational DataBase to assess clinicopathological correlations and concomitant pathology in neurodegenerative diseasesIsabelle Journe-Mallet, Julien Gouju, Frédérique Etcharry-Bouyx, et al.
European Journal of Human Genetics : EJHG|May 7, 2021
Evidence of mosaicism in SPAST variant carriers in four French familiesChloé Angelini, Cyril Goizet, Samia Ait Said, et al.
Frontiers in Neurology|July 24, 2019
International Guidelines for the Treatment of Huntington's DiseaseAnne-Catherine Bachoud-Lévi, Joaquim Ferreira, Renaud Massart, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2017
A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's diseaseChristophe Verny, Anne-Catherine Bachoud-Lévi, Alexandra Durr, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2025
Expanding the Allelic and Clinical Heterogeneity of Movement Disorders Linked to Defects of Mitochondrial Adenosine Triphosphate SynthasePhilip Harrer, Magdalena Krygier, Martin Krenn, et al.
Neurobiology of Disease|June 5, 2013
Association between caffeine intake and age at onset in Huntington's diseaseClémence Simonin, Cécile Duru, Julia Salleron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2021
Expanding the Spectrum of AP5Z1-Related Hereditary Spastic Paraplegia (HSP-SPG48): A Multicenter Study on a Rare DiseaseMarianthi Breza, Jennifer Hirst, Viorica Chelban, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neurology. Genetics|January 18, 2024
<i>IRF2BPL</i> Causes Mild Intellectual Disability Followed by Late-Onset AtaxiaSolveig Heide, Claire-Sophie Davoine, Paulina Cunha, et al.
Journal of Huntington'S Disease|February 20, 2025
Social cognition profile in early Huntington disease: Insight from neuropsychological assessment and structural neuroimagingMarie Caillaud, Mickael Laisney, Alexandre Bejanin, et al.
Orphanet Journal of Rare Diseases|February 19, 2018
Cyclosporine A does not prevent second-eye involvement in Leber's hereditary optic neuropathyStéphanie Leruez, Christophe Verny, Dominique Bonneau, et al.
Brain Pathology (Zurich, Switzerland)|December 20, 2022
Design and application of a customizable relational DataBase to assess clinicopathological correlations and concomitant pathology in neurodegenerative diseasesIsabelle Journe-Mallet, Julien Gouju, Frédérique Etcharry-Bouyx, et al.
European Journal of Human Genetics : EJHG|May 7, 2021
Evidence of mosaicism in SPAST variant carriers in four French familiesChloé Angelini, Cyril Goizet, Samia Ait Said, et al.
Frontiers in Neurology|July 24, 2019
International Guidelines for the Treatment of Huntington's DiseaseAnne-Catherine Bachoud-Lévi, Joaquim Ferreira, Renaud Massart, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2017
A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's diseaseChristophe Verny, Anne-Catherine Bachoud-Lévi, Alexandra Durr, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 25, 2025
Expanding the Allelic and Clinical Heterogeneity of Movement Disorders Linked to Defects of Mitochondrial Adenosine Triphosphate SynthasePhilip Harrer, Magdalena Krygier, Martin Krenn, et al.
Neurobiology of Disease|June 5, 2013
Association between caffeine intake and age at onset in Huntington's diseaseClémence Simonin, Cécile Duru, Julia Salleron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2021
Expanding the Spectrum of AP5Z1-Related Hereditary Spastic Paraplegia (HSP-SPG48): A Multicenter Study on a Rare DiseaseMarianthi Breza, Jennifer Hirst, Viorica Chelban, et al.
Pageof 3